Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Disc Medicine (IRON – Research Report) and keeping the price target at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback